Skip to main content

Table 1 Patient characteristics and their variables as predictors for disease-spesific survival in 335 NSCLC patients (univariate analyses; log-rank test)

From: Stage and tissue-specific prognostic impact of miR-182 in NSCLC

Characteristics

Patients

Median survival

5-year survival

P

 

n

(%)

months

%

 

Age

     

  ≤ 65 years

156

(47)

98

55

0.42

  >65 years

179

(53)

NR

60

 

Sex

     

  Female

82

(24)

190

64

0.22

  Male

253

(76)

98

56

 

Smoking

     

  Never

15

(5)

19

43

0.26

  Current

215

(64)

NR

60

 

  Former

105

(31)

84

55

 

Performance status

     

  PS 0

197

(59)

NR

63

0.016

  PS 1

120

(36)

64

52

 

  PS 2

18

(5)

25

33

 

Weight loss

     

  < 10%

303

(90)

190

58

0.76

  > 10%

32

(10)

98

57

 

Histology

     

  SCC

191

(57)

NR

66

0.028

  Adenocarcinoma

113

(34)

54

46

 

  LCC

31

(9)

98

56

 

Differentiation

     

  Poor

138

(41)

47

47

< 0.001

  Moderate

144

(43)

190

65

 

  Well

53

(16)

NR

68

 

Surgical procedure

     

  Lobectomy + wedge*

243

(73)

190

62

0.007

  Pneumonectomy

92

(27)

37

47

 

Pathological stage

     

  I

157

(47)

NR

61

< 0.001

  II

136

(40)

62

51

 

  IIIa

42

(13)

17

23

 

Tumor status

     

  1

85

(25)

190

75

< 0.001

  2

188

(56)

84

57

 

  3

62

(19)

25

36

 

Nodal status

     

  0

232

(69)

NR

67

< 0.001

  1

76

(23)

35

43

 

  2

27

(8)

18

18

 

Surgical margins

     

  Free

307

(92)

190

59

0.37

  Not free

28

(8)

47

48

 

Vascular infiltration

     

  No

284

(85)

190

62

0.001

  Yes

51

(15)

27

33

 
  1. Statistically significant results in bold font.
  2. *Wedge, n = 10.
  3. Abbreviations: NR not reached, PS performance status, SCC squamos cell carcinoma, LCC large-cell carcinoma. Adenocarcinoma including cases with bronchioloalveolar carcinoma.